Beranda7CA • FRA
add
Camurus AB
Tutup sebelumnya
€52,70
Rentang hari
€53,75 - €53,75
Rentang tahun
€40,88 - €62,60
Kapitalisasi pasar
34,68Â M SEK
Volume Rata-Rata
2,00
Rasio P/E
-
Hasil dividen
-
Bursa utama
STO
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (SEK) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 553,13Â jt | 47,67% |
Biaya operasional | 353,74Â jt | -2,56% |
Laba bersih | 146,98Â jt | 1.066,60% |
Margin laba bersih | 26,57 | 754,43% |
Penghasilan per saham | 2,45 | 1.007,41% |
EBITDA | 169,58Â jt | 1.089,33% |
Tarif pajak efektif | 21,08% | — |
Neraca
Total aset
Total liabilitas
| (SEK) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 2,85Â M | 139,75% |
Total aset | 3,76Â M | 96,93% |
Total liabilitas | 467,33Â jt | 12,66% |
Total ekuitas | 3,29 M | — |
Saham yang beredar | 58,64 jt | — |
Harga terhadap nilai buku | 0,94 | — |
Tingkat pengembalian aset | 11,34% | — |
Tingkat pengembalian modal | 12,90% | — |
Arus Kas
Perubahan kas bersih
| (SEK) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 146,98Â jt | 1.066,60% |
Kas dari operasi | 103,25Â jt | 244,05% |
Kas dari investasi | -19,89Â jt | -733,84% |
Kas dari pembiayaan | 15,43Â jt | 36,67% |
Perubahan kas bersih | 101,44Â jt | 181,88% |
Arus kas bebas | -10,21Â jt | -112,37% |
Tentang
Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap.
Camurus was founded by scientists in biophysical, food, and pharmaceutical chemistry with expertise in lipid phase structures. The company provides nanoscale drug-delivery systems for development of high-value therapeutics. Wikipedia
Didirikan
1991
Situs
Karyawan
256
